Respiratory syncytial virus genetic and antigenic diversity
- PMID: 10627488
- PMCID: PMC88930
- DOI: 10.1128/CMR.13.1.1
Respiratory syncytial virus genetic and antigenic diversity
Abstract
Respiratory syncytial virus (RSV) is a major cause of viral lower respiratory tract infections among infants and young children in both developing and developed countries. There are two major antigenic groups of RSV, A and B, and additional antigenic variability occurs within the groups. The most extensive antigenic and genetic diversity is found in the attachment glycoprotein, G. During individual epidemic periods, viruses of both antigenic groups may cocirculate or viruses of one group may predominate. When there are consecutive annual epidemics in which the same group predominates, the dominant viruses are genetically different from year to year. The antigenic differences that occur among these viruses may contribute to the ability of RSV to establish reinfections throughout life. The differences between the two groups have led to vaccine development strategies that should provide protection against both antigenic groups. The ability to discern intergroup and intragroup differences has increased the power of epidemiologic investigations of RSV. Future studies should expand our understanding of the molecular evolution of RSV and continue to contribute to the process of vaccine development.
Figures



Similar articles
-
Epidemiology. Does viral diversity matter?Science. 2009 Jul 17;325(5938):274-5. doi: 10.1126/science.1177475. Science. 2009. PMID: 19608903 No abstract available.
-
[Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus].Bing Du Xue Bao. 2015 Mar;31(2):201-6. Bing Du Xue Bao. 2015. PMID: 26164949 Review. Chinese.
-
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.J Virol. 1994 Sep;68(9):5448-59. doi: 10.1128/JVI.68.9.5448-5459.1994. J Virol. 1994. PMID: 8057427 Free PMC article.
-
Mucosal vaccines against respiratory syncytial virus.Curr Opin Virol. 2014 Jun;6:78-84. doi: 10.1016/j.coviro.2014.03.009. Epub 2014 Apr 29. Curr Opin Virol. 2014. PMID: 24794644 Free PMC article. Review.
-
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.Virology. 2000 Mar 30;269(1):54-65. doi: 10.1006/viro.2000.0186. Virology. 2000. PMID: 10725198
Cited by
-
The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.J Virol. 2013 Jul;87(14):8213-26. doi: 10.1128/JVI.03278-12. Epub 2013 May 22. J Virol. 2013. PMID: 23698290 Free PMC article.
-
Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment.bioRxiv [Preprint]. 2024 Sep 16:2024.09.16.613242. doi: 10.1101/2024.09.16.613242. bioRxiv. 2024. Update in: Sci Rep. 2025 Jul 1;15(1):20526. doi: 10.1038/s41598-025-03398-6. PMID: 39345650 Free PMC article. Updated. Preprint.
-
Genetic and antigenic variability of human respiratory syncytial virus (groups a and b) isolated over seven consecutive seasons in Argentina (1995 to 2001).J Clin Microbiol. 2005 May;43(5):2266-73. doi: 10.1128/JCM.43.5.2266-2273.2005. J Clin Microbiol. 2005. PMID: 15872254 Free PMC article.
-
The epidemiology and severity of respiratory viral infections in a tropical country: Ecuador, 2009-2016.J Infect Public Health. 2019 May-Jun;12(3):357-363. doi: 10.1016/j.jiph.2018.12.003. Epub 2018 Dec 17. J Infect Public Health. 2019. PMID: 30573330 Free PMC article.
-
Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.J Biol Chem. 2009 Mar 13;284(11):7294-306. doi: 10.1074/jbc.M806816200. Epub 2009 Jan 8. J Biol Chem. 2009. PMID: 19131335 Free PMC article.
References
-
- Akerlind B, Norrby E. Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol. 1986;19:241–274. - PubMed
-
- Akerlind B, Norrby E, Orvell C, Mufson M A. Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol. 1988;69:2145–2154. - PubMed
-
- Akerlind-Stopner B, Utter G, Norrby E, Mufson M A. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response. J Med Virol. 1995;47:120–125. - PubMed
-
- American Academy of Pediatrics Committee on Infectious Diseases. 1997 Redbook. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village: AAP; 1997.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical